Free Trial

Genmab A/S (GNMSF) Short Interest Ratio & Short Volume

Genmab A/S logo
$214.95 +2.40 (+1.13%)
As of 07/11/2025 11:55 AM Eastern

Genmab A/S Short Interest Data

Genmab A/S (GNMSF) has a short interest of 83,300 shares, representing 0.13% of the float (the number of shares available for trading by the public). This marks a 86.35% increase in short interest from the previous month. The short interest ratio (days to cover) is 833.0, indicating that it would take 833.0 days of the average trading volume of 36 shares to cover all short positions.

Current Short Interest
83,300 shares
Previous Short Interest
44,700 shares
Change Vs. Previous Month
+86.35%
Dollar Volume Sold Short
$17.58 million
Short Interest Ratio
833.0 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
66,070,000 shares
Short Percent of Float
0.13%
Today's Trading Volume
2 shares
Average Trading Volume
36 shares
Today's Volume Vs. Average
6%
Short Selling Genmab A/S?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Genmab A/S and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNMSF Short Interest Over Time

GNMSF Days to Cover Over Time

GNMSF Percentage of Float Shorted Over Time

Genmab A/S Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202583,300 shares $17.58 million +86.4%0.1%833 $211.09
6/15/202544,700 shares $10.03 million -62.1%0.1%111.8 $224.30
5/31/2025117,900 shares $24.49 million -19.4%0.2%1179 $207.75
5/15/2025146,300 shares $27.62 million +98.0%0.2%43 $188.80
4/30/202573,900 shares $15.15 million +1.2%N/A246.3 $204.98
4/15/202573,000 shares $13.91 million +30.1%0.1%4.3 $190.50
3/31/202556,100 shares $10.65 million +3.9%0.1%561 $189.80
3/15/202554,000 shares $11.28 million -11.6%0.1%180 $208.89
2/28/202561,100 shares $13.75 million -23.5%0.1%203.7 $224.97
2/15/202579,900 shares $16.86 million -1.2%0.1%21.6 $210.97
1/31/202580,900 shares $15.97 million -20.5%N/A3.8 $197.44
1/15/2025101,800 shares $20.57 million -16.6%N/A28.3 $202.06
12/31/2024122,000 shares $25.30 million +2.3%N/A16.9 $207.38
12/15/2024119,300 shares $23.98 million +9.5%N/A26.5 $201.00
11/30/2024109,000 shares $23.16 million +2.8%N/A7.2 $212.50
11/15/2024106,000 shares $22.55 million +38.9%N/A6.6 $212.71
10/31/202476,300 shares $16.67 million -10.1%N/A4.7 $218.47
10/15/202484,900 shares $19.93 million -19.1%N/A6.7 $234.80
9/30/2024104,900 shares $24.61 million -50.8%N/A80.7 $234.65
9/15/2024213,000 shares $55.32 million +3.3%N/A142 $259.72
8/31/2024206,200 shares $56.67 million +11.1%N/A114.6 $274.83
8/15/2024185,600 shares $49.24 million -1.2%N/A44.2 $265.28
7/31/2024187,900 shares $52.13 million +4.0%N/A19.4 $277.44
7/15/2024180,700 shares $46.58 million +19.5%N/A106.3 $257.77
6/30/2024151,200 shares $37.12 million +28.2%N/A116.3 $245.49
6/15/2024117,900 shares $30.47 million -0.6%N/A107.2 $258.44
5/31/2024118,600 shares $32.69 million +9.0%N/A107.8 $275.67
5/15/2024108,800 shares $31.72 million -49.4%N/A181.3 $291.54
4/30/2024214,900 shares $58.93 million +26.6%N/A126.4 $274.22
4/15/2024169,700 shares $47.86 million +7.3%N/A169.7 $282.00
3/31/2024158,100 shares $48.47 million -3.5%N/A175.7 $306.59
3/15/2024163,800 shares $49.40 million -4.1%N/A136.5 $301.60
2/29/2024170,800 shares $47.55 million +24.1%N/A27.5 $278.41
2/15/2024137,600 shares $39.55 million -11.6%N/A86 $287.40
1/15/202430,700 shares $9.65 million -4.7%N/A16.2 $314.40
12/31/202332,200 shares $10.17 million -1.5%N/A16 $315.70
12/15/202332,700 shares $10.19 million +1.6%N/A12.1 $311.50
11/30/202332,200 shares $10.27 million -42.7%N/A16.9 $319.00
11/15/202356,200 shares $18.21 million +102.2%N/A25.5 $324.07
10/31/202327,800 shares $7.98 million +1.1%N/A23.2 $287.10
Central Banks Are Hoarding Gold – Should You? (Ad)

The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and ushering in more economic uncertainty. Claim your FREE AI & Gold Report today and learn what central banks, investors, and analysts are seeing—and how gold can help protect your savings in an uncertain, AI-driven world.

▻ Get ahead of the trend—CLICK HERE to claim your FREE AI & Gold Report now!
10/15/202327,500 shares $8.77 million +10.0%N/A45.8 $319.00
9/30/202325,000 shares $8.91 million +113.7%N/A41.7 $356.30
9/15/202311,700 shares $4.40 million -0.9%N/A7.8 $376.20
8/31/202311,800 shares $4.47 million +6.3%N/A15.6 $379.20
8/15/202311,100 shares $4.09 million -31.5%N/A27.8 $368.40
7/31/202316,200 shares $6.65 million -38.2%N/A23.1 $410.40
7/15/202326,200 shares $10.36 million -36.7%N/A18.7 $395.43
6/30/202341,400 shares $15.51 million +19.7%N/A37.6 $374.57
6/15/202334,600 shares $13.30 million -5.5%N/A38.4 $384.50
5/31/202336,600 shares $14.46 million -42.6%N/A73.2 $394.99
5/15/202363,800 shares $27.06 million +69.2%N/A91.1 $424.10
4/30/202337,700 shares $15.41 million -37.5%N/A75.4 $408.70
4/15/202360,300 shares $24.87 million -28.4%N/A67 $412.50
3/31/202384,200 shares $31.47 million -18.7%N/A210.5 $373.75
3/15/2023103,600 shares $36.80 million +143.2%N/A172.7 $355.25
2/28/202342,600 shares $15.90 million -56.0%N/A60.9 $373.25
2/15/202396,900 shares $38.21 million +8.8%N/A193.8 $394.30
1/31/202389,100 shares $34.93 million -3.3%N/A148.5 $392.00
1/15/202392,100 shares $37.12 million +37.3%N/A153.5 $403.00
12/30/202267,100 shares $28.69 million +527.1%N/A41.9 $427.50
12/15/202210,700 shares $4.77 million +78.3%N/A3.8 $445.52
11/30/20226,000 shares $2.75 million -25.0%N/A10 $457.50
11/15/20228,000 shares $3.38 million +14.3%N/A6.7 $422.43
10/31/20227,000 shares $2.69 million -51.7%N/A0.8 $384.30
10/15/202214,500 shares $5.35 million +20.8%N/A11.2 $368.80
9/30/202212,000 shares $3.84 million +10.1%N/A10.9 $320.21
9/15/202210,900 shares $3.88 million -71.7%N/A7.8 $356.25
8/31/202238,500 shares $13.59 million -31.0%N/A55 $353.01
8/15/202255,800 shares $20.85 million +30.1%N/A27.9 $373.61
7/31/202242,900 shares $14.95 million +257.5%N/A39 $348.50
7/15/202212,000 shares $4.09 million -87.2%N/A7.1 $341.16
6/30/202294,000 shares $30.58 million -30.0%N/A16.2 $325.29
6/15/2022134,200 shares $36.61 million +63.7%N/A63.9 $272.80
5/31/202282,000 shares $24.77 million -60.0%N/A8 $302.08
5/15/2022204,900 shares $59.57 million +7.1%N/A113.8 $290.75
4/30/2022191,300 shares $69.71 million +92.7%N/A273.3 $364.42
4/15/202299,300 shares $36.64 million +95.9%N/A66.2 $368.95
3/31/202250,700 shares $18.10 million -4.7%N/A56.3 $357.10
3/15/202253,200 shares $18.22 million -23.8%N/A44.3 $342.42
2/28/202269,800 shares $23.25 million +13.1%N/A34.9 $333.03
2/15/202261,700 shares $20.30 million +5.5%N/A26.8 $328.98
1/31/202258,500 shares $20.03 million +290.0%N/A26.6 $342.38
1/15/202215,000 shares $5.16 million -38.3%N/A10 $344.28
12/31/202124,300 shares $9.49 million -66.7%N/A24.3 $390.53
12/15/202172,900 shares $27.46 million +74.0%N/A11.4 $376.72
11/30/202141,900 shares $15.97 million -17.8%N/A41.9 $381.08
11/15/202151,000 shares $21.14 million +351.3%N/A85 $414.58
10/29/202111,300 shares $5.09 million -33.5%N/A7.1 $450.50
10/15/202117,000 shares $7.60 million +33.9%N/A24.3 $446.95
9/30/202112,700 shares $5.37 million -11.8%N/A25.4 $423.08
Central Banks Are Hoarding Gold – Should You? (Ad)

The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and ushering in more economic uncertainty. Claim your FREE AI & Gold Report today and learn what central banks, investors, and analysts are seeing—and how gold can help protect your savings in an uncertain, AI-driven world.

▻ Get ahead of the trend—CLICK HERE to claim your FREE AI & Gold Report now!
9/15/202114,400 shares $6.08 million +25.2%N/A13.1 $422.08
8/31/202111,500 shares $5.49 million +0.9%N/A28.8 $477.57
8/13/202111,400 shares $5.18 million +22.6%N/A16.3 $454.38
7/30/20219,300 shares $4.17 million +34.8%N/A5.2 $448.87
7/15/20216,900 shares $3.03 million -13.8%N/A11.5 $438.47
6/30/20218,000 shares $3.38 million -31.6%N/A6.7 $422.32
6/15/202111,700 shares $5.10 million -58.4%N/A14.6 $435.68
5/28/202128,100 shares $11.52 million -64.5%N/A56.2 $409.92
5/14/202179,100 shares $29.48 million -26.7%N/A197.8 $372.72
4/30/2021107,900 shares $40.45 million +6.6%N/A269.8 $374.92
4/15/2021101,200 shares $35.77 million +19.8%N/A44 $353.50
3/31/202184,500 shares $26.73 million +14.8%N/A24.9 $316.28
3/15/202173,600 shares $23.74 million +46.0%N/A73.6 $322.50
2/26/202150,400 shares $17.39 million -40.1%N/A16.8 $345.00
2/12/202184,100 shares $34.26 million +557.0%N/A120.1 $407.32
1/29/202112,800 shares $5.26 million +12.3%N/A8 $411.00
1/15/202122,900 shares $10.04 million +97.4%N/A45.8 $438.42
12/31/202029,700 shares $12.01 million +29.7%N/A74.3 $404.45
12/15/202022,900 shares $8.95 million +97.4%N/A45.8 $390.69
11/30/202011,600 shares $4.35 million -11.5%N/A9.7 $375.01
11/15/202013,100 shares $4.81 million +13.9%N/A14.6 $366.96
10/30/202011,500 shares $3.98 million No ChangeN/A12.8 $346.21
10/15/202011,500 shares $4.43 million -35.0%N/A38.3 $385.31
9/30/202017,700 shares $6.50 million -80.7%N/A14.8 $367.16
9/15/202091,800 shares $34.27 million +37.2%N/A76.5 $373.30
8/31/202066,900 shares $25.24 million +5.5%N/A47.8 $377.29
8/14/202063,400 shares $23.14 million -11.3%N/A52.8 $365.04
7/31/202071,500 shares $23.95 million -0.4%N/A102.1 $334.90
7/15/202071,800 shares $25.35 million -30.5%N/A102.6 $353.00

GNMSF Short Interest - Frequently Asked Questions

What is Genmab A/S's current short interest?

Short interest is the volume of Genmab A/S shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 83,300 shares of GNMSF short. 0.13% of Genmab A/S's shares are currently sold short. Learn More on Genmab A/S's current short interest.

What is a good short interest ratio for Genmab A/S?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNMSF shares currently have a short interest ratio of 833.0. Learn More on Genmab A/S's short interest ratio.

What is a good short interest percentage for Genmab A/S?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of Genmab A/S's floating shares are currently sold short.

Is Genmab A/S's short interest increasing or decreasing?

Genmab A/S saw a increase in short interest in June. As of June 30th, there was short interest totaling 83,300 shares, an increase of 86.4% from the previous total of 44,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Genmab A/S's short interest compare to its competitors?

0.13% of Genmab A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genmab A/S: Takeda Pharmaceutical Co. (0.16%), Daiichi Sankyo Co., Ltd. - Sponsored ADR (0.00%), argenex SE (3.31%), BioNTech SE Sponsored ADR (2.65%), Summit Therapeutics PLC (24.12%), Teva Pharmaceutical Industries Ltd. (3.49%), Insmed, Inc. (5.33%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S Sponsored ADR (0.28%), Moderna, Inc. (19.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Genmab A/S stock?

Short selling GNMSF is an investing strategy that aims to generate trading profit from Genmab A/S as its price is falling. GNMSF shares are trading up $2.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genmab A/S?

A short squeeze for Genmab A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNMSF, which in turn drives the price of the stock up even further.

How often is Genmab A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNMSF, twice per month. The most recent reporting period available is June, 30 2025.




This page (OTCMKTS:GNMSF) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners